{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T12:40:15Z","timestamp":1792586415937,"version":"4.5.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,9]],"date-time":"2025-08-09T00:00:00Z","timestamp":1754697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,8,9]],"date-time":"2025-08-09T00:00:00Z","timestamp":1754697600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100031417","name":"Scottish Prison Service","doi-asserted-by":"publisher","award":["Procurement Reference 01865"],"award-info":[{"award-number":["Procurement Reference 01865"]}],"id":[{"id":"10.13039\/100031417","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100031417","name":"Scottish Prison Service","doi-asserted-by":"publisher","award":["Procurement Reference 01865"],"award-info":[{"award-number":["Procurement Reference 01865"]}],"id":[{"id":"10.13039\/100031417","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000275","name":"The Leverhulme Trust","doi-asserted-by":"crossref","award":["RC-2015-011"],"award-info":[{"award-number":["RC-2015-011"]}],"id":[{"id":"10.13039\/501100000275","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000275","name":"The Leverhulme Trust","doi-asserted-by":"crossref","award":["RC-2015-011"],"award-info":[{"award-number":["RC-2015-011"]}],"id":[{"id":"10.13039\/501100000275","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000275","name":"The Leverhulme Trust","doi-asserted-by":"crossref","award":["RC-2015-011"],"award-info":[{"award-number":["RC-2015-011"]}],"id":[{"id":"10.13039\/501100000275","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Harm Reduct J"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The detection of nitazene compounds in the United Kingdom has raised concerns among healthcare professionals, public health authorities, and law enforcement due to the increased risk of fatal overdose, particularly among opioid users. In response, nitazene testing strips have been distributed to help users identify these substances in drugs they may consume. However, to date, limited testing has been conducted on the effectiveness of these strips.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This study assesses the sensitivity and selectivity of a widely distributed nitazene immunoassay drug testing strip. The limit of detection and selectivity was examined for 36 nitazene analogs and 93 other drugs and cutting agents commonly encountered in illicit samples. The effectiveness of the test strips for the detection of metonitazene in the presence of other drugs was examined using a series of concentrations in solution in combination with other drugs. Testing of the strips was also carried out using authentic seized heroin samples.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The strips detected 28 out of 36 nitazene compounds (78%) with detection limits ranging from 250\u00a0ng\/mL to 100\u00a0\u00b5g\/mL. The strips did not provide positive results for 93 other drugs and cutting agents at a concentration of 100\u00a0\u00b5g\/mL. However, false positives were observed when testing seized heroin samples, caused by caffeine concentrations over 300\u00a0\u00b5g\/mL. False negatives were also seen for eight nitazene compounds.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Caution should be exercised when deploying these nitazene test strips as frontline presumptive tests in both criminal justice and public health contexts due to the observed false negative and false positive results. While the strips successfully detected a majority of nitazene compounds, their inability to identify certain analogs poses a risk of not detecting the presence of these potent opioids in the drug supply. Additionally, the occurrence of false positives, due to the presence of caffeine\u2014a common adulterant in illicit substances\u2014raises concerns about their suitability for use as a harm reduction method.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12954-025-01287-9","type":"journal-article","created":{"date-parts":[[2025,8,9]],"date-time":"2025-08-09T04:52:34Z","timestamp":1754715154000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Evaluation of nitazene immunoassay test strips for rapid in-situ detection of nitazene and nitazene analogs in illicit drug samples"],"prefix":"10.1186","volume":"22","author":[{"given":"Victoria","family":"Marland","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorna","family":"Nisbet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niamh","family":"Nic Da\u00e9id","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,9]]},"reference":[{"key":"1287_CR1","unstructured":"Drug-related deaths increase in Scotland: Public Health Scotland; 2024 [updated 20\/08\/2024. Available from https:\/\/publichealthscotland.scot\/news\/2024\/august\/drug-related-deaths-increase-in-scotland\/. Accessed 11 Feb 2025."},{"key":"1287_CR2","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.drugpo.2019.04.010","volume":"70","author":"M Zoorob","year":"2019","unstructured":"Zoorob M. Fentanyl shock: the changing geography of overdose in the United States. Int J Drug Policy. 2019;70:40\u20136.","journal-title":"Int J Drug Policy"},{"issue":"2","key":"1287_CR3","doi-asserted-by":"publisher","first-page":"e71","DOI":"10.1016\/S2468-2667(24)00001-X","volume":"9","author":"A Holland","year":"2024","unstructured":"Holland A, Copeland CS, Shorter GW, Connolly DJ, Wiseman A, Mooney J, et al. Nitazenes: heralding a second wave for the UK drug-related death crisis? Lancet Public Health. 2024;9(2):e71\u20132.","journal-title":"Lancet Public Health"},{"key":"1287_CR4","unstructured":"Drug-related deaths in Scotland in 2023\u2014additional data."},{"key":"1287_CR5","unstructured":": National Records of Scotland; 2024 [updated 20\/08\/2024. Available from https:\/\/www.nrscotland.gov.uk\/publications\/drug-related-deaths-in-scotland-in-2023\/. Accessed 11 Feb 2025."},{"issue":"4","key":"1287_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-2667(24)00024-0","volume":"9","author":"I Giraudon","year":"2024","unstructured":"Giraudon I, Abel-Ollo K, Vanaga-Ar\u0101ja D, Heudtlass P, Griffiths P. Nitazenes represent a growing threat to public health in Europe. Lancet Public Health. 2024;9(4): e216.","journal-title":"Lancet Public Health"},{"issue":"6","key":"1287_CR7","volume":"15","author":"J Pergolizzi Jr","year":"2023","unstructured":"Pergolizzi J Jr, Raffa R, LeQuang JAK, Breve F, Varrassi G. Old Drugs and new challenges: a narrative review of Nitazenes. Cureus. 2023;15(6): e40736.","journal-title":"Cureus"},{"issue":"4","key":"1287_CR8","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1002\/hlca.19600430412","volume":"43","author":"A Hunger","year":"1960","unstructured":"Hunger A, Kebrle J, Rossi A, Hoffmann K. Benzimidazol-derivate und verwandte heterocyclen III. Synthese von 1-aminoalkyl-2-nenzyl-nitro-benzimidazolen. Helv Chim Acta. 1960;43(4):1032\u201346.","journal-title":"Helv Chim Acta"},{"issue":"4","key":"1287_CR9","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1097\/FTD.0000000000000970","volume":"44","author":"E Montanari","year":"2022","unstructured":"Montanari E, Madeo G, Pichini S, Busard\u00f2 FP, Carlier J. Acute intoxications and fatalities associated with benzimidazole opioid (Nitazene analog) use: a systematic review. Therapeut Drug Monit. 2022;44(4):494.","journal-title":"Therapeut Drug Monit"},{"key":"1287_CR10","unstructured":"Sample results: Welsh Emerging Drugs and Identification of Novel Substances; 2025 [updated 2025. Available from https:\/\/www.wedinos.org\/db\/samples\/. Accessed 11 Feb 2025."},{"key":"1287_CR11","unstructured":"UNODC EWA: Nitazenes\u2014a new group of synthetic opioids emerges: United Nations Office on Drugs and Crime; 2024 [updated February 2024. Available from https:\/\/www.unodc.org\/LSS\/Announcement\/Details\/cbec8f4c-73aa-49ee-9e2b-75620af8a910. Accessed 11 Feb 2025."},{"issue":"1","key":"1287_CR12","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s12954-018-0276-0","volume":"16","author":"JE Goldman","year":"2019","unstructured":"Goldman JE, Waye KM, Periera KA, Krieger MS, Yedinak JL, Marshall BDL. Perspectives on rapid fentanyl test strips as a harm reduction practice among young adults who use drugs: a qualitative study. Harm Reduct J. 2019;16(1):3.","journal-title":"Harm Reduct J"},{"key":"1287_CR13","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.drugpo.2018.09.009","volume":"61","author":"MS Krieger","year":"2018","unstructured":"Krieger MS, Goedel WC, Buxton JA, Lysyshyn M, Bernstein E, Sherman SG, et al. Use of rapid fentanyl test strips among young adults who use drugs. Int J Drug Policy. 2018;61:52\u20138.","journal-title":"Int J Drug Policy"},{"issue":"1","key":"1287_CR14","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s12954-018-0213-2","volume":"15","author":"MS Krieger","year":"2018","unstructured":"Krieger MS, Yedinak JL, Buxton JA, Lysyshyn M, Bernstein E, Rich JD, et al. High willingness to use rapid fentanyl test strips among young adults who use drugs. Harm Reduct J. 2018;15(1):7.","journal-title":"Harm Reduct J"},{"key":"1287_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.addbeh.2020.106529","volume":"110","author":"JN Park","year":"2020","unstructured":"Park JN, Tomko C, Silberzahn BE, Haney K, Marshall BDL, Sherman SG. A fentanyl test strip intervention to reduce overdose risk among female sex workers who use drugs in Baltimore: Results from a pilot study. Addict Behav. 2020;110: 106529.","journal-title":"Addict Behav"},{"issue":"3","key":"1287_CR16","first-page":"288","volume":"30","author":"AH Khan","year":"2019","unstructured":"Khan AH, Shakeel S, Hooda K, Siddiqui K, Jafri L. Best practices in the implementation of a point of care testing program: experience from a tertiary care hospital in a developing country. Ejifcc. 2019;30(3):288\u2013302.","journal-title":"Ejifcc"},{"key":"1287_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.forc.2024.100605","volume":"40","author":"EK Hardwick","year":"2024","unstructured":"Hardwick EK, Tyler DJ. Structural characterization of nitazene analogs using electron ionization-mass spectrometry (EI-MS). Forensic Chem. 2024;40: 100605.","journal-title":"Forensic Chem"},{"key":"1287_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2020.102661","volume":"77","author":"TC Green","year":"2020","unstructured":"Green TC, Park JN, Gilbert M, McKenzie M, Struth E, Lucas R, et al. An assessment of the limits of detection, sensitivity and specificity of three devices for public health-based drug checking of fentanyl in street-acquired samples. Int J Drug Policy. 2020;77: 102661.","journal-title":"Int J Drug Policy"},{"issue":"1","key":"1287_CR19","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s12954-021-00478-4","volume":"18","author":"T-LE Lockwood","year":"2021","unstructured":"Lockwood T-LE, Vervoordt A, Lieberman M. High concentrations of illicit stimulants and cutting agents cause false positives on fentanyl test strips. Harm Reduct J. 2021;18(1):30.","journal-title":"Harm Reduct J"},{"key":"1287_CR20","doi-asserted-by":"publisher","first-page":"122904","DOI":"10.1016\/j.talanta.2021.122904","volume":"237","author":"A \u017bubrycka","year":"2022","unstructured":"\u017bubrycka A, Kwa\u015bnica A, Haczkiewicz M, Sipa K, Rudnicki K, Skrzypek S, et al. Illicit drugs street samples and their cutting agents. The result of the GC-MS based profiling define the guidelines for sensors development. Talanta. 2022;237:122904.","journal-title":"Talanta"},{"key":"1287_CR21","unstructured":"Deaths linked to potent synthetic opioids: Office for Health Improvement and Disparities, 2024 [updated 03\/10\/2024. Available from https:\/\/www.gov.uk\/government\/publications\/deaths-linked-to-potent-synthetic-opioids\/deaths-linked-to-potent-synthetic-opioids. Accessed 11 Feb 2025"},{"key":"1287_CR22","doi-asserted-by":"publisher","first-page":"100594","DOI":"10.1016\/j.forc.2024.100594","volume":"40","author":"E Sisco","year":"2024","unstructured":"Sisco E, Appley MG, Pyfrom EM, Banta-Green CJ, Shover CL, Molina CA, et al. Beyond fentanyl test strips: investigating other urine drug test strips for drug checking applications. Forensic Chem. 2024;40:100594.","journal-title":"Forensic Chem"},{"issue":"1","key":"1287_CR23","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1186\/s12954-024-01078-8","volume":"21","author":"LM De Vrieze","year":"2024","unstructured":"De Vrieze LM, Stove CP, Vandeputte MM. Nitazene test strips: a laboratory evaluation. Harm Reduct J. 2024;21(1):159.","journal-title":"Harm Reduct J"}],"container-title":["Harm Reduction Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12954-025-01287-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12954-025-01287-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12954-025-01287-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T19:44:28Z","timestamp":1757360668000},"score":1,"resource":{"primary":{"URL":"https:\/\/harmreductionjournal.biomedcentral.com\/articles\/10.1186\/s12954-025-01287-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,9]]},"references-count":23,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1287"],"URL":"https:\/\/doi.org\/10.1186\/s12954-025-01287-9","relation":{},"ISSN":["1477-7517"],"issn-type":[{"value":"1477-7517","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,9]]},"assertion":[{"value":"7 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"137"}}